News for Healthier Living

AI-Based Liquid Biopsy May Detect Liver Fibrosis, Cirrhosis and Chronic Disease Signals

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat landscapes can detect early liver fibrosis and cirrhosis, and may also reveal signals of broader chronic disease burden.

March 4, 2026


March 6 2026

March 5 2026

March 4 2026

March 3 2026

March 2 2026

March 1 2026

February 28 2026

February 27 2026

February 26 2026

February 25 2026

February 24 2026

February 23 2026

February 22 2026

February 21 2026

February 20 2026